Publication Date |
1987 |
Personal Author |
Sickles, D. W.; Wrenn, R. W.; Goldstein, B. D.; Coles, M.; Keldahl, C. |
Page Count |
25 |
Abstract |
The possible selective inhibition of oxidative enzymes in neural tissues by acrylamide (79061) (ACR) given intraperitoneally at dose levels of 50mg/kg/day for 5 or 10 days was investigated. A 17 to 20 percent reduction in NADH-tetrazolium-reductase (NADH-TR) activity in one motoneuron type was demonstrated along with a progressive decrease in retrograde transport of horseradish-peroxidase from the muscle to the motoneuron. Following an acute exposure, activity returned to control levels in 72 hours, indicating that ACR did not irreversibly damage the neuron oxidative metabolism. The nonneurotoxic analogue, methylene-bis-acrylamide was less effective in enzyme inhibition. A study of the effects of ACR and a nonneurotoxic analogue on the NADH-TR activity of neural and nonneural tissues indicated that ACR specifically inhibited neural specific NADH-TR activity. The effect of ACR on the specific enzymes lipoamide-dehydrogenase and cytochrome-c-reductase agreed with the NADH-TR histochemical data, except for the kidney studies. In general the neural tissue enzymes were more significantly affected than nonneural. The depletion of high energy phosphate was determined not to be the causative factor for deficits in axoplasmic transport caused by any of the neurotoxicants under study. |
Keywords |
|
Source Agency |
|
NTIS Subject Category |
|
Corporate Authors |
Medical Coll. of Georgia, Augusta.; National Inst. for Occupational Safety and Health, Cincinnati, OH. |
Supplemental Notes |
Sponsored by National Inst. for Occupational Safety and Health, Cincinnati, OH. |
Document Type |
Technical Report |
Title Note |
Final rept. 1 Aug 84-1 Jun 87, |
NTIS Issue Number |
198906 |